1、 Middle East&Africa Genetic Testing Services Market Market Size and Forecast(2020-2030)Regional Growth Opportunity Analysis Coverage:By Service Service TypeType(Predictive Testing,Carrier Testing,Prenatal Testing,Newborn Screening,and Others),DiseaseDisease(Cancer,Metabolic Diseases,Cardiovascular D

2、iseases,and Other Diseases),Service Service ProviderProvider(Hospital-Based Laboratories,Diagnostic Laboratories,and Others),and CountryCountry 2 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners Table of Content 1.Introduction.12 1.1 The Insight Partners Research Re

3、port Guidance.12 1.2 Market Segmentation.13 2.Executive Summary.14 2.1 Key Insights.14 3.Research Methodology.15 3.1 Coverage.16 3.2 Secondary Research.16 3.3 Primary Research.16 4.Middle East&Africa Genetic Testing Services Market-Key Industry Dynamics.18 4.1 Key Market Drivers.18 4.1.1 Rising Prev

4、alence of Genetic Diseases.18 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines.19 4.1.3 Growing Preference for Direct-To-Consumer(DTC)Genetic Testing.19 4.2 Market Restraints.20 4.2.1 Social and Ethical Implications of Genetic Testing.20 4.2.2 Affordability of Genetic Services.20

5、4.3 Market Opportunities.21 4.3.1 Untapped Emerging Markets in Developing Countries.21 4.4 Future Trends.21 4.4.1 Artificial Intelligence-Powered Genetic Testing.21 4.5 Impact Analysis:.22 5.Genetic Testing Services Market-Middle East&Africa Market Analysis.23 5.1 Middle East&Africa Genetic Testing

6、Services Market Revenue(US$Mn),2022 2030.23 6.Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030 by Service Type.24 6.1 Overview.24 6.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Type,2022&2030(%).24 6.3 Predictive Testing.25 6.3.1 Overvi

7、ew.25 3 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.3.2 Predictive Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).25 6.4 Carrier Testing.26 6.4.1 Overview.26 6.4.2 Carrier Testing:Middle East&Africa Genetic

8、 Testing Services Market Revenue and Forecast to 2030(US$Million).26 6.5 Prenatal Testing.27 6.5.1 Overview.27 6.5.2 Prenatal Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).27 6.6 Newborn Screening.28 6.6.1 Overview.28 6.6.2 Newborn Screening:Midd

9、le East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).28 6.7 Others.29 6.7.1 Overview.29 6.7.2 Others:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).29 7.Middle East&Africa Genetic Testing Services Market Revenue and Fore

10、cast to 2030 by Disease.30 7.1 Overview.30 7.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Disease,2022&2030(%).30 7.3 Cancer.31 7.3.1 Overview.31 7.3.2 Cancer:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).31 7.4 Cardiovascular Di

11、seases.32 7.4.1 Overview.32 7.4.2 Cardiovascular Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).32 7.5 Metabolic Diseases.33 7.5.1 Overview.33 7.5.2 Metabolic Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 203

12、0(US$Million).33 7.6 Other Diseases.34 7.6.1 Overview.34 7.6.2 Other Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).34 4 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 8.Middle East&Africa Genetic Testing Servi

13、ces Market Revenue and Forecast to 2030 by Service Provider.36 8.1 Overview.36 8.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Provider,2022&2030(%).36 8.3 Hospital-Based Laboratories.37 8.3.1 Overview.37 8.3.2 Hospital-Based Laboratories:Middle East&Africa Genetic Te

14、sting Services Market Revenue and Forecast to 2030(US$Million).37 8.4 Diagnostic Laboratories.38 8.4.1 Overview.38 8.4.2 Diagnostic Laboratories:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).38 8.5 Others.39 8.5.1 Overview.39 8.5.2 Others:Middle East&Afr

15、ica Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).39 9.Middle East&Africa Genetic Testing Services Market-Country Analysis.40 9.1 Middle East&Africa.40 9.1.1 Middle East&Africa Middle East&Africa Genetic Testing Services Market,by Country.40 9.1.1.1 Saudi Arabia.41 9.1.1.1

16、.1 Overview.41 9.1.1.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).41 9.1.1.1.3 Saudi Arabia Genetic Testing Services Market,by Service Type,20202030(US$Million).42 9.1.1.1.4 Saudi Arabia Genetic Testing Services Market,by Disease,20202030(US$Million).43 9.1.1.

17、1.5 Saudi Arabia Genetic Testing Services Market,by Service Provider,20202030(US$Million).43 9.1.1.2 UAE.44 9.1.1.2.1 Overview.44 9.1.1.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).44 9.1.1.2.3 UAE Genetic Testing Services Market,by Service Type,20202030(US$Million).45

18、 9.1.1.2.4 UAE Genetic Testing Services Market,by Disease,20202030(US$Million).45 9.1.1.2.5 UAE Genetic Testing Services Market,by Service Provider,20202030(US$Million).45 5 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.3 South Africa.46 9.1.1.3.1 Overview.

19、46 9.1.1.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).46 9.1.1.3.3 South Africa Genetic Testing Services Market,by Service Type,20202030(US$Million).47 9.1.1.3.4 South Africa Genetic Testing Services Market,by Disease,20202030(US$Million).48 9.1.1.3.5 South Af

20、rica Genetic Testing Services Market,by Service Provider,20202030(US$Million).48 9.1.1.4 Rest of Middle East&Africa.49 9.1.1.4.1 Overview.49 9.1.1.4.2 Rest of Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).49 9.1.1.4.3 Rest of Middle East&Africa Genetic Testin

21、g Services Market,by Service Type,20202030(US$Million).50 9.1.1.4.4 Rest of Middle East&Africa Genetic Testing Services Market,by Disease,20202030(US$Million).50 9.1.1.4.5 Rest of Middle East&Africa Genetic Testing Services Market,by Service Provider,20202030(US$Million).51 10.Genetic Testing Servic

22、es MarketIndustry Landscape.52 10.1 Overview.52 10.2 Growth Strategies in Middle East&Africa Genetic Testing Services Market.52 10.3 Organic Growth Strategies.53 10.3.1 Overview.53 10.4 Inorganic Growth Strategies.54 10.4.1 Overview.54 11.Company Profiles.56 11.1 Eurofins Scientific SE.56 11.1.1 Key

23、 Facts.56 11.1.2 Business Description.56 11.1.3 Products and Services.57 11.1.4 Financial Overview.58 11.1.5 SWOT Analysis.59 11.1.6 Key Developments.60 11.2 Exact Sciences Corp.61 11.2.1 Key Facts.61 11.2.2 Business Description.61 6 Middle East&Africa Genetic Testing Services Market,2020-2030 |The

24、Insight Partners 11.2.3 Products and Services.61 11.2.4 Financial Overview.62 11.2.5 SWOT Analysis.63 11.2.6 Key Developments.64 11.3 Laboratory Corp of America Holdings.65 11.3.1 Key Facts.65 11.3.2 Business Description.65 11.3.3 Products and Services.65 11.3.4 Financial Overview.66 11.3.5 SWOT Ana

25、lysis.67 11.3.6 Key Developments.68 11.4 Quest Diagnostics Inc.69 11.4.1 Key Facts.69 11.4.2 Business Description.69 11.4.3 Products and Services.70 11.4.4 Financial Overview.70 11.4.5 SWOT Analysis.71 11.4.6 Key Developments.72 11.5 Illumina Inc.73 11.5.1 Key Facts.73 11.5.2 Business Description.73

26、 11.5.3 Products and Services.74 11.5.4 Financial Overview.74 11.5.5 SWOT Analysis.75 11.5.6 Key Developments.76 11.6 F.Hoffmann-La Roche Ltd.77 11.6.1 Key Facts.77 11.6.2 Business Description.77 11.6.3 Products and Services.78 11.6.4 Financial Overview.78 11.6.5 SWOT Analysis.80 11.6.6 Key Developm

27、ents.82 11.7 Centogene AG.83 11.7.1 Key Facts.83 11.7.2 Business Description.83 7 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 11.7.3 Products and Services.83 11.7.4 Financial Overview.84 11.7.5 SWOT Analysis.85 11.7.6 Key Developments.86 12.Appendix.87 12.1 Abo

28、ut Us.87 12.2 Glossary of Terms.88 8 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners List of Tables Table 1.Middle East&Africa Genetic Testing Services Market Segmentation.13 Table 2.Saudi Arabia Genetic Testing Services Market,by Service Type Revenue and Forecast

29、to 2030(US$Million).42 Table 3.Saudi Arabia Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million).43 Table 4.Saudi Arabia Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million).43 Table 5.UAE Genetic Testing Services Market,by Servi

30、ce Type Revenue and Forecast to 2030(US$Million).45 Table 6.UAE Middle East&Africa Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million).45 Table 7.UAE Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million).45 Table 8.South Africa G

31、enetic Testing Services Market,by Service Type Revenue and Forecast to 2030(US$Million).47 Table 9.South Africa Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million).48 Table 10.South Africa Genetic Testing Services Market,by Service Provider Revenue and Forecast to 203

32、0(US$Million).48 Table 11.Rest of Middle East&Africa Genetic Testing Services Market,by Service Type Revenue and Forecast to 2030(US$Million).50 Table 12.Rest of Middle East&Africa Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million).50 Table 13.Rest of Middle East&Afr

33、ica Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million).51 Table 14.Recent Organic Growth Strategies in Middle East&Africa Genetic Testing Services Market.53 Table 15.Recent Inorganic Growth Strategies in the Middle East&Africa Genetic Testing Services Market

34、.54 Table 16.Glossary of Terms,Middle East&Africa Genetic Testing Services Market.88 9 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners List of Figures Figure 1.Middle East&Africa Genetic Testing Services Market Segmentation,By Country.13 Figure 2.Middle East&Africa

35、 Genetic Testing Services Market-Key Industry Dynamics.18 Figure 3.Impact Analysis of Drivers and Restraints.22 Figure 4.Middle East&Africa Genetic Testing Services Market Revenue(US$Mn),2022 2030.23 Figure 5.Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Type,2022&2030(

36、%).24 Figure 6.Predictive Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).25 Figure 7.Carrier Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).26 Figure 8.Prenatal Testing:Middle East&Africa Geneti

37、c Testing Services Market Revenue and Forecast to 2030(US$Million).27 Figure 9.Newborn Screening:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).28 Figure 10.Others:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)

38、.29 Figure 11.Middle East&Africa Genetic Testing Services Market Revenue Share,by Disease,2022&2030(%).30 Figure 12.Cancer:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).31 Figure 13.Cardiovascular Diseases:Middle East&Africa Genetic Testing Services Mark

39、et Revenue and Forecast to 2030(US$Million).32 Figure 14.Metabolic Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).33 Figure 15.Other Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).35 Figure 16

40、.Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Provider,2022&2030(%).36 Figure 17.Hospital-Based Laboratories:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).37 Figure 18.Diagnostic Laboratories:Middle East&Africa Genetic Test

41、ing Services Market Revenue and Forecast to 2030(US$Million).38 10 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners Figure 19.Others:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million).39 Figure 20.Middle East&Africa Middle Ea

42、st&Africa Genetic Testing Services Market,by Key Country Revenue,2022(US$Million).40 Figure 21.Middle East&Africa Middle East&Africa Genetic Testing Services Market,By Key Countries,2022 and 2030(%).40 Figure 22.Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).42 Figu

43、re 23.UAE Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).44 Figure 24.South Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).47 Figure 25.Rest of Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn).49 Figure 26.Growth

44、Strategies in Middle East&Africa Genetic Testing Services Market.52 11 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners NOTES:The list of companies included in the scope are as per standard report format and the list can be modified/expanded as per clients requireme

45、nt The sequence/list of companies do not represent their current position in the market.The list of countries provided in the report are part of standard report and can be customized as per clients requirement RELATED REPORTS Newborn Genetic Testing Market DTC Genetic Testing Market 12 Middle East&A

46、frica Genetic Testing Services Market,2020-2030 |The Insight Partners 1.Introduction 1.1 The Insight Partners Research Report Guidance The report provides qualitative and quantitative trends of Middle East&Africa genetic testing services market across service type,disease,service provider,and countr

47、y.The report starts with the key takeaways(chapter 2),highlighting the key trends and outlook of the Middle East&Africa genetic testing services market.Chapter 3 provides the research methodology of the study.Chapter 4 highlights the key industry dynamics in the Middle East&Africa genetic testing se

48、rvices market,including factors that are driving the market,prevailing deterrent,potential opportunities as well as future trends.Impact analysis of these drivers and restraints is also covered in this section.Chapter 5 discusses the Middle East&Africa genetic testing services market scenario,in ter

49、ms of historical market revenues,and forecast till 2030.Chapter 6 to 9 discuss genetic testing services market segments by service type,disease,service provider,and countries across the Middle East&Africa.They cover market revenue forecast,and factors driving and governing growth.Chapter 10 describe

50、s the industry landscape analysis.It provides detailed description of various business activities such as market initiatives,new developments,mergers,and joint ventures globally along with a competitive landscape.Chapter 11 provides the detailed profiles of the key companies operating in the Middle

51、East&Africa genetic testing services market.The companies have been profiled on the basis of their key facts,business description,products and services,financial overview,SWOT analysis,and key developments.Chapter 12,i.e.the appendix is inclusive of a brief overview of the company,glossary of terms,

52、contact information,and the disclaimer section.13 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 1.2 Market Segmentation Table 1.Middle East&Africa Genetic Testing Services Market Segmentation SERVICE TYPESERVICE TYPE DISEASEDISEASE SERVICE PROVIDERSERVICE PROVIDE

53、R PREDICTIVE TESTING CANCER HOSPITAL-BASED LABORATORIES CARRIER TESTING CARDIOVASCULAR DISEASES DIAGNOSTIC LABORATORIES PRENATAL TESTING METABOLIC DISEASES OTHERS NEWBORN SCREENING OTHER DISEASES OTHERS Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources

54、Figure 1.Middle East&Africa Genetic Testing Services Market Segmentation,By Country Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources The Middle East&Africa genetic testing services market is segmented based on service type,disease,service provider,and

55、country.The segmentation in this research study has been finalized post in-depth secondary research and extensive primary research.In addition,the market is also segmented on the basis of services offered by the leading participants in the industry in order to understand widely used market specific

56、terminologies.Thus,we have incorporated the segments of the research and have finalized the market segmentation.MIDDLE EAST&AFRICASAUDI ARABIASOUTH AFRICAUAEREST OF MEA 14 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 2.Executive Summary 2.1 Key Insights Overview

57、Market SegmentationMarket DynamicsRegional OverviewMarket SegmentationKey PlayersMarket DynamicsCAGR(2022-2030)12.5%Market Size 2022$78.07MnMarket Size 2030$200.38MnService TypeDisease Predictive Testing Carrier Testing Prenatal Testing Newborn Screening Others Cancer Cardiovascular Diseases Metabol

58、ic Diseases Other Diseases Laboratory Corporation of America Holdings F.Hoffmann-La Roche Ltd Illumina,Inc.Quest Diagnostics Incorporated Exact Sciences Corp(Genomic Health)Eurofins Scientific Centogene AG 23andMe,IncGROWTH DRIVERSFUTURE TRENDSGROWTH DRIVERSFUTURE TRENDS Rising Prevalence of Genetic

59、 Diseases Increasing Awareness and Acceptance of Personalized Medicines Artificial Intelligence-Powered Genetic TestingRESTRAINTSOPPORTUNITY Social and Ethical Implications of Genetic Testing Affordability of Genetic Services Untapped Emerging Markets in Developing CountriesService Provider Hospital

60、-Based Laboratories Diagnostic Laboratories OthersMIDDLE EAST&AFRICA12.5%15 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 3.Research Methodology The Insight Partners dedicated research and analysis team consist of experienced professionals with advanced statistic

61、al expertise in market research and consulting backgrounds in in various industries including Aerospace and Defense,Automotive and Transportation,Biotechnology,Chemicals and Materials,Food and Beverages,Electronics and Semiconductor,Healthcare IT,Manufacturing and Construction,Medical Device,Technol

62、ogy,Media and Telecommunications.Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources FinalMarket sizeValidation from Primary InterviewSummation of Revenue Generated from Companies to arrive Total Market SizeRevenue Generated by the Products and Services O

63、ffered by Companies in the Genetic Testing Service MarketFinal Market Size Break-Up To Rest Of Segmentation(i.e.,Service Type,Disease,Service Provider,and Region)Arriving at the Market Size of each Segment Validation of Number with Primary Interviews and Subject Matter Expert BOTTOM-UP ANALYSISTOP-D

64、OWN ANALYSIS 16 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners The Insight Partners adheres to the codes of practice of the Market Research Society(www.mrs.org.uk)and Strategic and Competitive Intelligence Professionals(www.scip.org).The following methodology has

65、been followed for the collection and analysis of data presented in this report:3.1 Coverage The objective of updating“The Insight Partners”coverage is to ensure that it represents the most up-to-date vision of the industry possible.The estimated revenues of all major companies,including private and

66、governmental,are gathered and used to prioritize coverage.Companies which are making the news,or which are of particular interest due to their innovative approach,are prioritized.3.2 Secondary Research The research process begins with exhaustive secondary research using internal and external sources

67、 to obtain qualitative and quantitative information relating to each Market.The secondary research sources that are typically referred to include,but are not limited to:Company websites,annual reports,financial reports,broker reports and investor presentations Industry trade journals and other liter

68、ature National government documents,statistical databases and market reports News articles,press releases and web-casts specific to the companies operating in the market NOTE:All the financials considered in Company Profiles section have been standardized to US$.This has been achieved after converti

69、ng the financials(for those not in US$)with respective currency exchange rates of the particular year.3.3 Primary Research“The Insight Partners”conducts hundreds of primary interviews a year with industry participants and commentators in order to validate its data and analysis.A typical research int

70、erview fulfils the following functions:Provides first-hand information on the market size,market trends,growth trends,competitive landscape and future outlook Validates and strengthens secondary research findings Further develops the analysis teams expertise and market understanding 17 Middle East&A

71、frica Genetic Testing Services Market,2020-2030 |The Insight Partners Primary research involves email interactions and telephone interviews for each market,category,segment and sub-segment across countries.The participants who typically take part in such a process include,but are not limited to:Indu

72、stry participants:VPs,business development managers,market intelligence managers and national sales managers Outside experts:Valuation experts,research analysts and key opinion leaders specializing in the industry 18 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners

73、4.Middle East&Africa Genetic Testing Services Market-Key Industry Dynamics Figure 2.Middle East&Africa Genetic Testing Services Market-Key Industry Dynamics Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources 4.1 Key Market Drivers 4.1.1 Rising Prevalence

74、 of Genetic Diseases The prevalence of genetic diseases is rising across the world and impacting the health of people at a severe level.Genetic diseases show many symptoms that are uncommon and are mostly non-curable.Most of the genetic diseases are rare and are developed due to the mutation in the

75、genetic makeup of the people.According to The World Health Organization(WHO)2021,10 out of every 1,000 people are affected by single-gene diseases,signifying that 70 million and 80 million people worldwide are living with any one type of single-gene disease.As per the Global Genes,7,000 known rare d

76、iseases and disorders have been identified worldwide,and more are being discovered every year.According to the University of Sheffield research,300 million people are living with genetic diseases around the world.In Asia Pacific and the Middle East,a very large population is diagnosed with genetic d

77、iseases due to consanguineous marriage favored in many communities.Marriages between relatives are the major concern for the rising prevalence of genetic diseases.The burden of autosomal recessive disease variations is high in Saudi Arabia due to the highly consanguineous population.To control these

78、 conditions,countries in the Middle East are mandatorily conducting genetic evaluations for couples getting married DROTDRIVERSRESTRAINTSOPPORTUNITIESTRENDSRising Prevalence of Genetic DiseasesIncreasing Awareness and Acceptance of Personalized MedicinesGrowing Preference for Direct-To-Consumer Gene

79、tic TestingSocial and Ethical Implications of Genetic TestingAffordability of Genetic ServicesArtificial Intelligence-Powered Genetic TestingUntapped Emerging Markets in Developing Countries 19 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners so that the prevalence

80、of these diseases can be managed and treated timely.Thus,the rising prevalence of genetic diseases fuels the demand for genetic testing,which in turn drives genetic testing services market growth.4.1.2 Increasing Awareness and Acceptance of Personalized Medicines Personalized medicine is the field t

81、hat utilizes patients genetic and environmental data to deliver optimal healthcare.It is based on the principle that every patient is unique and requires individualistic pharmacological treatment.Since it is a rapidly evolving area,it is presently incorporated into several healthcare systems.The suc

82、cessful completion of the Human Genome Project(HGP)in 2003 and the fast-decreasing human genome sequencing costs encouraged the development of a new medical approach,which is called personalized medicine.With an expanding repository of personalized data at the molecular level,molecular diagnostics c

83、ompanies are exceptionally positioned to unlock value.Large-scale drug discovery is a key to increasing the viability and usefulness of personalized medicines for the diagnosis of diseases and disorders.Genomics is one of the fastest-growing divisions of medical science.It is driving a paradigm shif

84、t in the research methodology of a disease,as well as diagnosing and treating illness.Genetic testing has been extensively used in pharmacogenomics,also known as drug-gene testing.It helps in accelerating drug discovery and its development.In January 2023,The Human Genome Project is ensuring an era

85、of personalized healthcare.Now,new research shows that precision prescribing using genetic testing has ultimately reached a global tipping point for adoption.Published by Cambridge University Press,the peer-reviewed research examines the maturation of critical factors required for the use of clinica

86、l genetics at scale.These advancements pave the way for supporting genome-informed clinical decision-making to be established as the new standard of care.Genetically informed prescribing offers one of the realistic mechanisms to successfully reduce the overall costs of the healthcare system and impr

87、ove individual patient care.Genetic testing encourages the adoption of a personalized medicine approach by understanding the science behind the disease,the impact of treatment,and the development of therapies for specific individual characteristics.It also helps healthcare personnel make informed de

88、cisions about disease diagnosis,treatment,and prevention by utilizing genetic testing results,leading to improved patient outcomes.4.1.3 Growing Preference for Direct-To-Consumer(DTC)Genetic Testing Personalized genetic testing and treatment have long been used globally to help individuals and famil

89、ies learn more about hereditary diseases.Most of the time,genetic testing is done through healthcare personnel,such as genetic counselors.Healthcare providers decide which test is needed,order the test from a test center,collect and send the DNA sample,read the test results,and share the results wit

90、h the patient.Thus,these tests have traditionally been ordered and interpreted in a clinical or medical research setting.In contrast,DTC genetic testing has witnessed tremendous growth in the past decade and is becoming increasingly widespread.A genetic test offered,advertised,and sold by companies

91、directly to the consumer,without the direct involvement of a conventional healthcare system,is called DTC genetic testing.DTC genetic testing is relatively new and helps people find out about the disease-associated genes they may carry without the need for a prescription or guidance from a genetic c

92、ounselor or medical practitioner.Several consumers of DTC testing view it as another method of gathering medical information about themselves.Unlike other genetic tests performed in clinics or hospitals,the consumer independently initiates and completes a DTC genetic test.The public understanding an

93、d acceptance of genetic testing is gradually increasing.Additionally,there is a rise in consumers seeking customized products and experiences for the identification and addressing of unique needs.The launch of innovative products and the increase in the adoption of DTC genetic testing kits have made

94、 genetic testing 20 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners more accessible to people.These kits enable users to undergo personalized health management within the comfort of their homes.Key industry players are also developing DTC genetic tests and implemen

95、ting special marketing efforts that positively impact sales of DTC tests.A rising number of manufacturers are providing direct-to-consumer genetic testing that covers various health conditions and traits.The increasing demand for direct-to-consumer genetic testing products to learn about the genetic

96、 makeup and assess the risk of developing hereditary conditions for early disease detection or prevention drives the market.4.2 Market Restraints 4.2.1 Social and Ethical Implications of Genetic Testing Genetic testing is poised to play an important role in the practice of obstetrics and gynecology.

97、Physicians are required to become familiar with the presently accessible collection of genetic tests and their limitations to guarantee patients the utmost quality of care.However,the knowledge of genetic risks can result in potential social and psychological consequences for the people undergoing s

98、uch tests.Socially,knowledge from genetic tests may lead to stigmatization and judgment within the community.Refusing to undergo genetic testing,as well as choosing to undergo genetic testing,can both lead to discrimination and stigmatization,depending on the prevalent public standards concerning ac

99、ceptance and use of the technology.Privacy and security concerns also arise as the availability and commercialization of personal genetic data can lead to unauthorized access or misuse of sensitive information.The storage of genetic testing data and registries of patients generates concern,given tha

100、t the results can negatively impact the family members.In addition,lack of informed consent can lead to adverse reactions,such as increased anxiety and unnecessary preventive measures during the disclosure of genetic test results.Lack of proper counseling regarding the information about genetic risk

101、 and choices regarding genetic testing and its management can cause potential psychological distress.Therefore,the reluctance of patients to prefer genetic testing due to the social and ethical stigma impedes market growth.4.2.2 Affordability of Genetic Services At present,genetic services are expen

102、sive and,therefore,not accessible to all.Genetic research is presently underrepresented in health research;however,studies are being conducted to establish the feasibility of such services.Present inequalities in the affordability and feasibility of genetic services are a cause of concern for the WH

103、O and other prominent international organizations that are centered around public health and development concerns.The cost of the test also increases if more than one test is needed or if multiple family members need to be tested to obtain a significant result.For newborn screening,costs differ as p

104、er the state.Several states cover part of the overall cost,although most charge a fee of US$30 to US$150 per infant.Various factors,including the type of test,the complexity of analysis,and laboratory processing fees,influence the cost of these tests.Thus,the high costs,along with its affordability

105、in emerging economies,restrain the market growth.21 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 4.3 Market Opportunities 4.3.1 Untapped Emerging Markets in Developing Countries Emerging countries such as China,India,Brazil,and Mexico offer significant growth op

106、portunities to market players.The high growth can majorly be attributed to the increasing public healthcare expenditure,improving healthcare infrastructure,and the presence of a large target patient population.The need for genetic testing has also increased owing to a rise in awareness of genetic di

107、sorders in developing economies and their early diagnosis.The quality and availability of genetic services may differ between high-income countries and low-to middle-income countries.For instance,in the US,Australia,Canada,the UK,and other European countries,genetic services are well-advanced,establ

108、ished,and extensive.These services include newborn screening,carrier identification screening,and prenatal diagnosis.Yet,in many high-income countries,genetic services that are offered in multiple settings still need improved systems of assessment.The ease and applicability of genetic testing proced

109、ures have benefitted R&D activities in developing regions worldwide.Major market players are focusing on strategies and initiatives,such as agreements,collaborations,partnerships,and expansions,to improve their product availability,accessibility,and distribution networks in these countries,as it wil

110、l help them address the growing need for early diagnosis and treatment.For instance,in 2024,in Almarkaziya,Abu Dhabi,Central Clinic has launched its most recent and cutting-edge genomic testing services.Also,in 2023,Burjeel Holdings teamed up with OncoHelix Inc.to open a state-of-the-art lab in Abu

111、Dhabi that would offer patients in the UAE cutting-edge molecular genetics,cellular,and immunological profile testing.In addition,rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.Therefore,emerging markets in developing cou

112、ntries are expected to offer significant opportunities to the players operating in the market and boost the market growth during the forecast period.4.4 Future Trends 4.4.1 Artificial Intelligence-Powered Genetic Testing Whole-genome sequencing and now whole-exome sequencing have also become more po

113、pular.To solve the growing problem of health data exhaust,the field of medicine is increasingly revolving around enhanced clinical tools,such as artificial intelligence(AI)and machine learning,which have been mentioned as a way to improve the acceptance of genomic medicine.Today,many companies have

114、turned to machine learning to process the vast amount of data needed to correctly analyze and understand clinical data in fields such as radiology and cardiology.Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function.In

115、numerous ways,genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with.For example,working on the human genome includes reading billions of bits of information,and prior to the introduction of machine learning

116、,many of these tasks were pretty tricky.AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a p

117、ersons genetic information.Moreover,agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics.Furthermore,Blueprint Genetics is using AI in clinical interpretation.Machine learning and AI ar

118、e acting as a catalyst for faster and more diverse improvement in genetic research and engineering.These tools are simple to integrate and extremely scalable,putting genetic laboratories in a unique position to scale their operations and match the fast growth 22 Middle East&Africa Genetic Testing Se

119、rvices Market,2020-2030 |The Insight Partners of the genetic testing field.Thus,through the successful integration of these tools,clinicians will be able to diagnose rare genetic diseases more efficiently and effectively,bringing hope to the millions of people affected by them globally.4.5 Impact An

120、alysis:The following figure depicts the impact of factors driving and restraining the Middle East&Africa genetic testing services market.The factors driving the market growth include increasing prevalence of genetic diseases,increasing awareness and acceptance of personalized medicines,and growing p

121、reference for direct-to-consumer genetic testing.However,social and ethical implications of genetic testing and affordability of genetic services hinders the market growth.Figure 3.Impact Analysis of Drivers and Restraints Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journal

122、s,Secondary Sources Rising Prevalence of Genetic DiseasesGrowing Preference towards for Direct-To-Consumer Genetic TestingSocial and Ethical Implications of Genetic TestingLOWMEDIUMHIGHIncreasing Awareness and Acceptance of Personalized Medicines 23 Middle East&Africa Genetic Testing Services Market

123、,2020-2030 |The Insight Partners 5.Genetic Testing Services Market-Middle East&Africa Market Analysis The Middle East&Africa genetic testing services market in the Middle East&Africa is segmented into UAE,Saudi Arabia,South Africa,and the Rest of the Middle East&Africa.The market is driven by progra

124、ms undertaken by a number of research institutes and the availability of infrastructure and facilities for research in the UAE and Saudi Arabia.The support by the government in these countries are likely to boost the growth of the market.Moreover,the increase in the incidence of genetic disorders an

125、d cancer plays an important role in the development of the genetic testing industry.5.1 Middle East&Africa Genetic Testing Services Market Revenue(US$Mn),2022 2030 The Middle East&Africa genetic testing services market is expected to reach US$200.38 million by 2030 from US$78.07 million in 2022.The

126、market is estimated to grow at a CAGR of 12.5%from 2022 to 2030.The factors driving the market growth include the increasing prevalence of genetic diseases,growing preference for direct-to-consumer genetic testing,and increasing awareness and acceptance of personalized medicines.However,social and e

127、thical implications of genetic testing and affordability of genetic services restrain the growth of the market.Figure 4.Middle East&Africa Genetic Testing Services Market Revenue(US$Mn),2022 2030 Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources 64.9071

128、.1678.0786.1595.60106.68119.71135.06153.22174.76200.389.7%9.7%10.3%11.0%11.6%12.2%12.8%13.4%14.1%14.7%0.0%2.0%4.0%6.0%8.0%10.0%12.0%14.0%16.0%202020212022202320242025202620272028202920300501001502002502020-2030Historical YearBase YearForecast Year 24 Middle East&Africa Genetic Testing Services Marke

129、t,2020-2030 |The Insight Partners 6.Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030 by Service Type 6.1 Overview The Middle East&Africa genetic testing services market,by service type,is segmented into predictive testing,carrier testing,prenatal testing,newborn screen

130、ing,and others.In 2022,the predictive testing segment held the largest share of the market and is expected to register the highest CAGR in the market during the coming years.6.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Type,2022&2030(%)Figure 5.Middle East&Africa G

131、enetic Testing Services Market Revenue Share,by Service Type,2022&2030(%)Source:The Insight Partners Analysis The predictive testing segment led the market in 2022 with a share of 43.2%and is expected to retain its dominance during 20222030 by accounting for 46.5%of the total market by 2030.43.2%25.

132、1%10.6%13.0%8.1%2022Predictive TestingCarrier TestingPrenatal TestingNew-born ScreeningOthers46.5%25.6%9.6%12.7%5.6%2030 25 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.3 Predictive Testing 6.3.1 Overview Predictive genetic testing examines any genetic changes

133、 or mutations that are linked to disease.These tests are done prior to an individual displaying any signs of a disease.Predictive testing can be helpful to people who have a family history of a treatable genetic disorder and display no signs of illness.This testing can identify mutations that increa

134、se an individuals risk of developing disorders with a genetic foundation,such as certain types of cancer.An example is testing for the BRCA1 and BRCA2 gene variants(altered genes)linked with an increased risk of breast cancer.The results of predictive testing can provide information about the probab

135、ility of developing a specific disorder and help in making decisions about medical care.The increasing demand for genetic counseling is expected to drive the market for predictive testing as more people understand the importance of genetics in disease etiology.The ongoing advancements and upgrading

136、of platforms to improve the efficiency of genome analysis techniques are expected to boost the adoption of predictive testing solutions.A growing focus on reducing the growing healthcare burden of rare genetic diseases and rapid integration of technologies such as artificial intelligence and machine

137、 learning will enhance product development and fuel the need for predictive testing to assess and prevent future complications arising from diseases effectively.6.3.2 Predictive Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Predictive testing segm

138、ent was valued at US$33.73 million in 2022 and is expected to reach US$93.25 million by 2030.The growth rate of this segment is projected to be 13.6%during 20222030.Figure 6.Predictive Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insig

139、ht Partners Analysis,Primary Interviews,Secondary Sources 27.4930.4433.7337.5742.1047.4253.7161.1770.0380.6093.25202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 26 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.4 Carrie

140、r Testing 6.4.1 Overview Carrier testing is a kind of genetic test that can tell whether one carries a gene for certain genetic disorders or not.When it is done before or during pregnancy,it helps to find out the chances of having a child with a genetic disorder.Carrier testing is used to identify p

141、eople carrying one copy of a gene mutation(a genetic change)that,when present in two copies,results in a genetic disorder.Carriers generally do not have symptoms or have only mild symptoms.They often are unaware that they have a gene for a disorder.Carrier screening is offered for a limited number o

142、f diseases,including cystic fibrosis,sickle cell disease,fragile X syndrome,and TaySachs disease.A few of these disorders occur commonly in certain ethnic groups.For example,sickle cell disease occurs most frequently in African Americans.TaySachs disease is most common in Eastern or Central European

143、 Jewish people,French Canadian people,and Cajun descent.Although,anyone can have one of these disorders as they are not restricted to these groups.With the increasing prevalence of genetic diseases caused by chromosome and gene mutations,carrier testing has grown exponentially.The majority of cases

144、of genetic mutations are due to preexisting conditions,a family history of abortion,or congenital disabilities.Pregnant women often undergo carrier screening in order to determine the risk of transmitting a specific genetic disease to their progeny.In addition,the increasing recognition of the impor

145、tance of early diagnosis and screening of gene illness fuels the need to develop strategies to tackle these diseases.6.4.2 Carrier Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Carrier testing segment was valued at US$19.59 million in 2022 and is

146、expected to reach US$51.21 million by 2030.The growth rate of this segment is projected to be 12.8%during 20222030.Figure 7.Carrier Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sou

147、rces 16.2117.8119.5921.6624.1026.9530.3134.2838.9844.5651.21202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 27 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.5 Prenatal Testing 6.5.1 Overview Genetics can have an impact

148、 on the color of a babys eyes and hair and can also result in the development of some birth defects or genetic disorders.This testing helps to detect abnormalities in a fetuss genes or chromosomes and syndromes before birth.Thats why women are regularly offered a wide range of prenatal genetic testi

149、ng in the first and second trimesters of pregnancy to evaluate the problems in their unborn babies.According to the WHO,congenital disabilities affect 8 million newborns every year.Nine out of every ten children are born with a serious birth defect in low-and middle-income countries.Congenital disab

150、ilities can occur at any point through the pregnancy;however,most of them occur during the first trimester when the babys organs are formed.6.5.2 Prenatal Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Prenatal testing segment was valued at US$8.28

151、 million in 2022 and is expected to reach US$19.28 million by 2030.The growth rate of this segment is projected to be 11.1%during 20222030.Figure 8.Prenatal Testing:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary

152、 Interviews,Secondary Sources 7.047.648.289.039.9110.9212.1113.5015.1217.0319.28202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 28 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.6 Newborn Screening 6.6.1 Overview A newb

153、orn screening test looks for various developmental,genetic,and metabolic disease disorders in the newborn.Newborn screening allows measures to be taken before symptoms develop.Most of these illnesses are extremely rare but can be treated if detected early.The offspring has a high risk of having gene

154、tic diseases in cases where the parents have another child with a genetic disease,a family history of a genetic disorder,or if either of a parent has a chromosomal abnormality.Early testing for these conditions allows physicians and parents to take timely measures to manage,treat,or intervene in dis

155、ease progression,allowing the baby to lead a healthy,normal life.6.6.2 Newborn Screening:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Newborn screening segment was valued at US$10.15 million in 2022 and is expected to reach US$25.49 million by 2030.The g

156、rowth rate of this segment is projected to be 12.2%during 20222030.Figure 9.Newborn Screening:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 8.499.2810.1511.1712.3613.7515.3917.3219.

157、5922.2925.49202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 29 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 6.7 Others 6.7.1 Overview The others segment is comprised of preimplantation testing and pharmacogenomics.These

158、 tests are performed to screen for genetic disorders.Pharmacogenomics testing is a type of genetic test that is used to identify the right medication for a person.Pharmacogenomics is one of the key emerging trends in the field of medical science,which significantly impacts the drug development proce

159、ss.With the use of pharmacogenomics,target identification by drugs has become comparatively easy,which confirms much higher chances of success for the approval of drugs.Preimplantation genetic testing is also for couples who are at risk of having a child with a specific genetic or chromosome disorde

160、r,e.g.,cystic fibrosis or sickle cell disease.In this procedure,egg cells are removed from the womans ovaries and fertilized with sperm cells outside the body.The fertilized embryos develop for three days,and subsequently,one or two cells are removed from each embryo.The genetic material(DNA and chr

161、omosomes)from the cells is tested for the genetic disorder in the family history.One or two of the unaltered embryos are then relocated into the mothers womb(uterus).If the pregnancy is successful,the baby will not be affected by the disorder it was tested for.6.7.2 Others:Middle East&Africa Genetic

162、 Testing Services Market Revenue and Forecast to 2030(US$Million)Others segment was valued at US$6.33 million in 2022 and is expected to reach US$11.16 million by 2030.The growth rate of this segment is projected to be 7.3%during 20222030.Figure 10.Others:Middle East&Africa Genetic Testing Services

163、Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 5.686.006.336.717.147.638.188.809.5010.2811.16202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 30 Middle East&Africa Genetic Testing Serv

164、ices Market,2020-2030 |The Insight Partners 7.Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030 by Disease 7.1 Overview The Middle East&Africa genetic testing services market,by disease,is segmented into cancer,cardiovascular diseases,metabolic diseases,and other diseas

165、es.In 2022,the cancer segment held the largest share of the market and is anticipated to grow at the highest CAGR during the coming years.7.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Disease,2022&2030(%)Figure 11.Middle East&Africa Genetic Testing Services Market Revenue S

166、hare,by Disease,2022&2030(%)Source:The Insight Partners Analysis The cancer segment led the market in 2022 with a share of 45.2%and is expected to retain its dominance during 20222030 by accounting for 49.0%of the total market by 2030.45.2%22.7%17.1%15.0%2022CancerCardiovascular DiseasesMetabolic Di

167、seasesOther Diseases49.0%23.7%16.4%11.0%2030 31 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 7.3 Cancer 7.3.1 Overview Genetic testing is a potential tool to identify individuals who are at higher risk for developing certain cancers because of family history.Gen

168、etic tests are available to examine inherited variants and alterations in the DNA sequence,which could result in excessive cell growth and can cause tumors or cancer.For example,genetic testing for the detection of PALB2(linked with increased risks of breast and pancreatic cancers),BRIP1(ovarian can

169、cer),RAD51C and RAD51D(ovarian cancer),and CHEK2(breast and colorectal cancers).The worldwide growing prevalence of various cancers,such as breast,lung,and bowel,are the major drivers of this segment.CDCs Cancer Genomics Program develops best practices in education,surveillance,and policy and system

170、s transformation approaches.It establishes an evidence base for the application of family history and cancer genomics in public health practice.Other factors that might impact cancer genetic testing awareness include DTC marketing of cancer genetic testing and federal regulations of genetic informat

171、ion,high awareness regarding the availability of quality cancer diagnostics tests,and the escalating incidence of hereditary diseases.In addition,a growing number of companies providing genomic profiling services for health assessment,including cancer risk prediction,and the availability of numerous

172、 laboratories offering genetic testing for BRCA,and other genes associated with hereditary breast,ovarian,and related cancers propel the market for the segment.7.3.2 Cancer:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Cancer segment was valued at US$35.3

173、1 million in 2022 and is expected to reach US$98.19 million by 2030.The growth rate of this segment is projected to be 13.6%during 20222030.Figure 12.Cancer:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Intervi

174、ews,Secondary Sources 28.7331.8435.3139.3644.1349.7656.4064.2773.6484.8198.19202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 32 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 7.4 Cardiovascular Diseases 7.4.1 Overview Hea

175、rt diseases are a prominent cause of death worldwide and often run in families.In addition,as per the World Heart Federation 2023,rare cardiovascular diseases(CVD)are common,affecting 5%of the global population.There are over 6,000 known rare diseases,a handful of which impact the heart and circulat

176、ory system.And 83%of physicians agree that genetic testing is useful in finding the diagnosis.Certain CVD conditions,such as cardiomyopathy,arrhythmia,and connective tissue disease,are caused by a single harmful DNA variation(or mutation).However,others,such as heart attack and high blood pressure,a

177、re usually caused by the combined effect of many smaller-impact DNA variations.More than 1 in 200 people have an inherited form of CVD disease,but most are unaware of it.Patients with an inherited cardiovascular condition display few or no symptoms but still face significant risk of heart disease,in

178、cluding sudden cardiovascular arrest.Genetic testing can help save lives and is informative and useful for the clinical management and treatment of numerous inherited CVDs.7.4.2 Cardiovascular Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Cardiov

179、ascular diseases segment was valued at US$17.74 million in 2022 and is expected to reach US$47.39 million by 2030.The growth rate of this segment is projected to be 13.1%during 20222030.Figure 13.Cardiovascular Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(

180、US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 14.6016.0917.7419.6821.9524.6127.7631.4835.8841.1347.39202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 33 Middle East&Africa Genetic Testing Services Market,2020-2030 |The

181、Insight Partners 7.5 Metabolic Diseases 7.5.1 Overview Diagnosis through genetic testing can strongly help discover the cause of persistent,often debilitating,undiagnosed signs in individuals suffering from suspected genetic metabolic disease disorders.With knowledge of variants in over 1,250 metabo

182、lic disease disorders genes,the rapid testing and experience of metabolic diseases can help to diagnose and manage the patients metabolic disease disorders quickly and correctly.Ultimately,this can provide new insights into treatment choices and the probability of passing the inherited condition on

183、to the offspring or the presence of it elsewhere in the extended family.CentoICU is a comprehensive next-generation sequencing panel that includes genes explicitly chosen for the genetic testing of extremely ill newborns and children under 24 months in intensive care units.In addition,Prevention Gen

184、etics offers a wide variety of genetic testing for inherited metabolic disease disorders,also known as inborn errors of metabolism.Panels specific to one disorder are available,as well as comprehensive metabolic diseases panels that cover broader phenotypic features or groups of similar disorders ar

185、e also offered,including tests for hyperammonemia(37 genes),metabolic diseases hypoglycemia(38 genes),and metabolic diseases myopathies,rhabdomyolysis,and exercise intolerance(83 genes).Over the past year,the company has started to offer several new tests related to these metabolic disorders,and man

186、y of the existing panels have been updated to include more genes and increase clinical sensitivity.7.5.2 Metabolic Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Metabolic diseases segment was valued at US$13.32 million in 2022 and is expected to

187、reach US$32.82 million by 2030.The growth rate of this segment is projected to be 11.9%during 20222030.Figure 14.Metabolic Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 11.

188、1812.2013.3214.6216.1417.9220.0122.4625.3528.7732.82202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 34 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 7.6 Other Diseases 7.6.1 Overview The others segment by disease compris

189、es Duchenne Muscular Dystrophy(DMD),Thalassemia,Huntingtons Disease,and Fragile X Syndrome,among others.Genetic mutations that cause DMD fail to produce dystrophin protein.Recessive diseases caused by alterations in genes on the X chromosome include DMD and fragile X syndrome.Genetic testing is used

190、 to diagnose Duchenne,to access mutation-specific therapies,and for family planning.For Duchenne,the dystrophin gene is examined to detect the presence of any changes or mutations that can inhibit the gene from working properly.Genetic testing is generally performed on a blood or saliva sample.A tha

191、lassemia is a group of inherited,genetic blood disorders that occur when the production of hemoglobin is disrupted.The disease is passed to children by parents carrying the mutated thalassemia gene.A kid who inherits one mutated gene is a carrier,and most carriers lead a completely normal and health

192、y life.At the same time,a child who inherits two thalassemia trait genes,i.e.,one from each parent,will have the disease.A child of two carriers has a 25 percent chance of developing the disease and a 50 percent chance of being a carrier.Thus,in such cases,genetic testing is helpful in detecting and

193、 diagnosing thalassemia.Currently,two major approaches are used in DNA diagnosis and study of genetic disease,namely direct tests and indirect tests(linkage analysis).Direct tests are being conducted for thalassemia and DMD.Carrier testing can be conducted for X-linked recessive disorders,such as DM

194、D or fragile X syndrome.In these cases,the mother of an affected child with no other affected relatives may desire carrier testing to confirm whether the disease is a heritable trait or a new mutation.Many diseases may become apparent only in middle age or later.Predictive or presymptomatic testing

195、and screening can provide symptoms that people may later develop these disorders.In some cases,a family history of a monogenic disorder in a relative informs other members of the family that they are at high risk for developing the disease.Suitable genetic testing can help to resolve whether the mut

196、ant gene is present or not.Examples include Huntingtons disease.7.6.2 Other Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Other diseases segment was valued at US$11.71 million in 2022 and is expected to reach US$21.97 million by 2030.The growth r

197、ate of this segment is projected to be 8.2%during 20222030.35 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners Figure 15.Other Diseases:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Pr

198、imary Interviews,Secondary Sources 10.3811.0311.7112.4913.3714.3915.5416.8618.3520.0521.97202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 36 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 8.Middle East&Africa Genetic Test

199、ing Services Market Revenue and Forecast to 2030 by Service Provider 8.1 Overview The Middle East&Africa genetic testing services market,by service provider,is segmented into hospital-based laboratories,diagnostic laboratories,and others.In 2022,the hospital-based laboratories segment held the large

200、st share of the market and is estimated to grow at the highest CAGR during 20222030.8.2 Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Provider,2022&2030(%)Figure 16.Middle East&Africa Genetic Testing Services Market Revenue Share,by Service Provider,2022&2030(%)Source:T

201、he Insight Partners Analysis The hospital-based laboratories segment led the market in 2022 with a share of 63.3%and is expected to retain its dominance during 20222030 by accounting for 67.6%of the total market by 2030.63.3%24.3%12.4%2022Hospital-BasedLaboratoriesDiagnostic LaboratoriesOther End Us

202、ers67.6%24.6%7.8%2030 37 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 8.3 Hospital-Based Laboratories 8.3.1 Overview Hospital-based laboratories are genetic testing service providers that operate within a hospital setting.For extremely specialized tests,samples

203、may go to a research laboratory.Nearly all hospitals contain a laboratory,which is commonly proportionate in size to the population it serves.The hospitals process hundreds of samples in very les time.Tests that are performed include those needed in emergencies,such as markers for heart attack and t

204、ests where results are required rapidly for patient care.They may also offer carrier testing to determine if an individual is carriers of certain genetic conditions that can be passed on to their children.Hospital laboratories can be segmented by type of testing and staffed by personnel trained in p

205、articular specialties.For instance,some sections can focus on microbiology,hematology,chemistry,and blood banking.At the same time,some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry,and others can focus on surgical pathology and cytology,which

206、are all linked with the investigation of cell and tissue structure.The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions.8.3.2 Hospital-Based Laboratories:Middle East&Africa Genetic Testing Services

207、 Market Revenue and Forecast to 2030(US$Million)Hospital-based laboratories segment was valued at US$49.42 million in 2022 and is expected to reach US$135.52 million by 2030.The growth rate of this segment is projected to be 13.4%during 20222030.Figure 17.Hospital-Based Laboratories:Middle East&Afri

208、ca Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 40.3844.6649.4255.0061.5569.2678.3789.15101.97117.25135.52202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 38

209、 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 8.4 Diagnostic Laboratories 8.4.1 Overview Diagnostics laboratories are independent entities that provide all the diagnostic tests,screening tests,and others to the patient.These centers may be found attached to a pr

210、ivate or public hospital.The tests performed in the diagnostic centers are obtained earlier than hospitals.The diagnostic centers also offer packages for whole-body check-ups that are cost-effective for the patients.Tests such as cell-free fetal DNA testing,triple or quadruple screening tests,sequen

211、tial screening,and others require advanced techniques,equipment,and skilled labor.However,some of the hospitals and clinics do not have all the required equipment and techniques for efficient diagnosis.Therefore,various hospitals and clinics prefer to outsource tests to diagnostics centers.The diagn

212、ostics centers are well equipped and offer better results for the tests performed for diseases and health conditions.The diagnostic centers provide multiple tests under one roof and offer all the prenatal diagnostics services such as screening,imaging,blood tests,chorionic villus sampling,and amnioc

213、entesis.Thus,it becomes easier for people to undergo genetic testing in such facilities.The growing partnerships and collaboration of diagnostic laboratories with genetic testing companies and the rise in the incidences of genetic diseases across the world are anticipated to offer growth to the mark

214、et.For instance,Thermo Fisher Scientific allows laboratories to perform different genetic research and genetic testing by offering technologies such as NGS and quantitative PCR.8.4.2 Diagnostic Laboratories:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Di

215、agnostic laboratories segment was valued at US$18.94 million in 2022 and is expected to reach US$49.23 million by 2030.The growth rate of this segment is projected to be 12.7%during 20222030.Figure 18.Diagnostic Laboratories:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to

216、2030(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Secondary Sources 15.7017.2418.9420.9323.2626.0029.2233.0237.5242.8649.23202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 39 Middle East&Africa Genetic Testing Services Market,2020-2030

217、|The Insight Partners 8.5 Others 8.5.1 Overview The others segment by service provider comprises academic and research institutions,pharmaceutical and biotechnology companies,and government agencies.Government agencies use genetic testing services to evaluate drugs for regulatory compliance for publ

218、ic health monitoring and research initiatives.Academic and research institutions are integral to the Middle East&Africa genetic testing services market.They help in identifying genetic markers,developing new genetic testing methodologies,and improving existing tests.These institutions validate and e

219、nsure the quality of genetic tests through rigorous studies,establishing their reliability and credibility.Clinical trials and studies conducted by these institutions provide essential evidence on the clinical utility and effectiveness of genetic tests.Their expertise and research efforts advance th

220、e growth of the market,benefiting both patients and healthcare providers.In addition,research and academic institutes are among the leading users of genetic testing services.Academic institutes for medical sciences and biotechnology utilize analytical testing services to support their studies on dru

221、gs.Thus,the increasing demand for genetic testing services from government agencies and research institutes will likely continue to drive the Middle East&Africa genetic testing services market for the segment.8.5.2 Others:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 203

222、0(US$Million)Others segment was valued at US$9.71 million in 2022 and is expected to reach US$15.63 million by 2030.The growth rate of this segment is projected to be 6.1%during 20222030.Figure 19.Others:Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Million)Sourc

223、e:The Insight Partners Analysis,Primary Interviews,Secondary Sources 8.829.269.7110.2210.7911.4212.1212.8913.7414.6515.63202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 40 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.

224、Middle East&Africa Genetic Testing Services Market-Country Analysis 9.1 Middle East&Africa Figure 20.Middle East&Africa Middle East&Africa Genetic Testing Services Market,by Key Country Revenue,2022(US$Million)Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary S

225、ources 9.1.1 Middle East&Africa Middle East&Africa Genetic Testing Services Market,by Country Figure 21.Middle East&Africa Middle East&Africa Genetic Testing Services Market,By Key Countries,2022 and 2030(%)Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sour

226、ces MIDDLE EAST&AFRICA(2022)22.206.8525.4223.60RoMEAUAESouth AfricaSaudi Arabia30.2%32.6%8.8%28.4%2022Saudi ArabiaSouth AfricaUAERest of Middle East&Africa33.2%32.4%8.5%26.0%2030 41 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.1 Saudi Arabia 9.1.1.1.1 Over

227、view In Saudi Arabia,the burden of genetic diseases and congenital disabilities is rising constantly due to the culture of consanguineous marriage.The genetic diseases show up in the form of severe inherited diseases;they affect 8%of births in the Kingdom of Saudi Arabia.The Government of Saudi Arab

228、ia has made it mandatory to undergo premarital genetic testing before marriage to check genetic compatibility to reduce hereditary blood diseases such as sickle cell and beta-thalassemia,which are most prevalent in the country.Therefore,the rising prevalence of genetic diseases and increasing premar

229、ital genetic testing in the country offer opportunities to the market.The growing number of cancer cases has also fueled cancer research in Saudi Arabia.As per Globocan 2020 data,the country recorded 27,885 new cancer cases.The 5-year prevalence rate for cancer in all ages was found to be 237.4 per

230、100,000 people.As per the IEEE Pulse,a magazine of the IEEE Engineering in Medicine and Biology Society,there is a high burden on the national health system due to these diseases.According to the IEEE Pulse,the cost of these diseases per year is nearly US$27 billion.If there is a reduction in the nu

231、mber of babies born with genetic diseases,it could save up to US$270 million.In June 2023,Centogene NV and Lifera,a biopharmaceutical company,entered into a strategic collaboration to increase local and regional access,rapid delivery of world-class multiomic testing to patients in Saudi Arabia and c

232、ountries of the Gulf Cooperation Council,as well as to establish a network for genetic testing services in the country.Centogene provides its leading diagnostics and multiomics expertise to the joint venture,which,together with Liferas strong local presence and resources,help to establish widespread

233、 access to local state-of-the-art genetic sequencing tailored to regional needs.The joint venture will develop capabilities for genetic testing and interpretation,working collaboratively with Centogene globally.Thus,the factors mentioned above support the growth of the market.9.1.1.1.2 Saudi Arabia

234、Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)Saudi Arabia genetic testing services market accounted for US$23.60 Mn in 2022 and it is expected to grow at a CAGR of 13.8%during the period 2022-2030,to reach US$66.45 Mn in 2030.42 Middle East&Africa Genetic Testing Services Marke

235、t,2020-2030 |The Insight Partners Figure 22.Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources 9.1.1.1.3 Saudi Arabia Genetic Testing Services Market,by Service Type,20202030

236、(US$Million)Table 2.Saudi Arabia Genetic Testing Services Market,by Service Type Revenue and Forecast to 2030(US$Million)Service Type 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Predictive Testing 7.76 8.71 9.78 11.04 12.53 14.30 16.40 18.92 21.93 25.55 29.92 15.0%Carrier Te

237、sting 4.62 5.13 5.71 6.39 7.19 8.13 9.24 10.57 12.14 14.03 16.30 14.0%Prenatal Testing 2.40 2.63 2.88 3.17 3.51 3.90 4.37 4.91 5.54 6.29 7.18 12.1%Newborn Screening 2.77 3.07 3.40 3.80 4.25 4.79 5.43 6.19 7.09 8.16 9.44 13.6%Others 1.60 1.71 1.83 1.97 2.12 2.30 2.50 2.73 2.99 3.28 3.61 8.9%Source:Th

238、e Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the predictive testing segment was worth US$9.78 million in 2022 and is projected to reach US$29.92 million by 2030;it is expected to grow at a CAGR

239、of 15.0%from 2022 to 2030.19.1421.2523.6026.3629.6033.4237.9443.3149.6957.3166.45202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 43 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.1.4 Saudi Arabia Genetic Testing Ser

240、vices Market,by Disease,20202030(US$Million)Table 3.Saudi Arabia Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million)Disease 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Cancer 8.50 9.52 10.68 12.03 13.64 15.54 17.80 20.50 23.74 27.62 32.30 14.8

241、%Cardiovascular Diseases 4.30 4.80 5.36 6.01 6.79 7.71 8.80 10.10 11.65 13.51 15.74 14.4%Metabolic Diseases 3.30 3.65 4.04 4.50 5.04 5.67 6.41 7.29 8.34 9.58 11.07 13.4%Others 3.05 3.28 3.53 3.81 4.14 4.51 4.93 5.42 5.97 6.61 7.34 9.6%Source:The Insight Partners Analysis,Primary Interviews,Magazines

242、 and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the cancer segment was worth US$10.68 million in 2022 and is projected to reach US$32.30 million by 2030;it is expected to grow at a CAGR of 14.8%from 2022 to 2030.9.1.1.1.5 Saudi Arabia Genetic Testing Se

243、rvices Market,by Service Provider,20202030(US$Million)Table 4.Saudi Arabia Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million)Service Provider 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Hospital-Based Laboratories 11.87 13.30 14.91 1

244、6.81 19.05 21.71 24.87 28.65 33.16 38.59 45.14 14.9%Diagnostic Laboratories 4.64 5.16 5.74 6.43 7.23 8.18 9.31 10.65 12.24 14.15 16.44 14.1%Others 2.64 2.79 2.95 3.12 3.32 3.53 3.76 4.01 4.28 4.57 4.86 6.5%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary S

245、ources The Middle East&Africa genetic testing services market for the hospital-based laboratories segment was worth US$14.91 million in 2022 and is projected to reach US$45.14 million by 2030;it is expected to grow at a CAGR of 14.9%from 2022 to 2030.44 Middle East&Africa Genetic Testing Services Ma

246、rket,2020-2030 |The Insight Partners 9.1.1.2 UAE 9.1.1.2.1 Overview The UAE is always at the forefront of providing the best facilities to its citizens and believes in building a healthy society for its citizens.In 2019,the UAE government launched an initiative to set up a state-of-the-art Genome Ce

247、nter to use the benefits of genetic science.It also focused on the implementation of modern and novel techniques,which consist of DNA sequencing,profiling,and microarray.The initiative intends to control the spread of non-communicable diseases such as cancer and provide the platform to create person

248、alized medicine programs for patients.The Ministry of Health and Prevention(MOHAP)also collaborated with Pure Health Laboratory Network to launch the first phase of the genome center in the country.The aim is to create a genome database for all genetic diseases in the UAE.In November 2023,the Depart

249、ment of HealthAbu Dhabi(DoH),in line with its continuous efforts to upskill the national healthcare workforce,launched the Clinical Genomic Medicine and Genetic Counselling Program for 100 Emirati physicians from diverse healthcare facilities across the country.The six-month program is the regions f

250、irst program offered by experts from Harvard Medical School Teaching Hospitals.It aims to equip medical professionals with the essential knowledge and skills to handle genetic and genomic issues in the clinical setting.Similarly,in November 2022,Illumina inaugurated its Illumina Solutions Centre in

251、Dubai.The Centre is furnished with genetic testing equipment,such as a fully operational lab with the latest NGS technologies.It offers training in diagnostic tests,such as noninvasive prenatal screening or genomic tests for cancer.Thus,the factors mentioned above are likely to support the Middle Ea

252、st&Africa genetic testing services market growth in the country during 20222030.9.1.1.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)The UAE genetic testing services market accounted for US$6.85 Mn in 2022 and it is expected to grow at a CAGR of 12.0%during the period 202

253、2-2030,to reach US$16.94 Mn in 2030.Figure 23.UAE Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources 5.756.286.857.538.319.2310.3111.5813.0814.8416.942020202120222023202420252026202720282

254、02920302020-2030Historical YearBase YearForecast Year 45 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.2.3 UAE Genetic Testing Services Market,by Service Type,20202030(US$Million)Table 5.UAE Genetic Testing Services Market,by Service Type Revenue and Foreca

255、st to 2030(US$Million)Service Type 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Predictive Testing 2.34 2.58 2.84 3.15 3.51 3.93 4.43 5.01 5.71 6.53 7.51 12.9%Carrier Testing 1.38 1.51 1.65 1.82 2.01 2.24 2.50 2.81 3.18 3.62 4.13 12.2%Prenatal Testing 0.69 0.75 0.81 0.88 0.96

256、 1.06 1.17 1.31 1.46 1.64 1.86 10.9%Newborn Screening 0.78 0.85 0.93 1.02 1.12 1.24 1.38 1.55 1.74 1.97 2.24 11.7%Others 0.55 0.59 0.62 0.66 0.71 0.77 0.83 0.90 0.99 1.08 1.19 8.4%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Afr

257、ica genetic testing services market for the predictive testing segment was worth US$2.84 million in 2022 and is projected to reach US$7.51 million by 2030;it is expected to grow at a CAGR of 12.9%from 2022 to 2030.9.1.1.2.4 UAE Genetic Testing Services Market,by Disease,20202030(US$Million)Table 6.U

258、AE Middle East&Africa Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million)Disease 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Cancer 2.58 2.83 3.11 3.44 3.82 4.27 4.79 5.42 6.15 7.03 8.06 12.7%Cardiovascular Diseases 1.29 1.42 1.56 1.72 1.91 2.

259、13 2.39 2.69 3.05 3.48 3.99 12.5%Metabolic Diseases 1.00 1.10 1.20 1.31 1.45 1.61 1.80 2.03 2.29 2.60 2.96 12.0%Others 0.88 0.93 0.99 1.06 1.14 1.23 1.33 1.45 1.58 1.74 1.92 8.6%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Afric

260、a genetic testing services market for the cancer segment was worth US$3.11 million in 2022 and is projected to reach US$8.06 million by 2030;it is expected to grow at a CAGR of 12.7%from 2022 to 2030.9.1.1.2.5 UAE Genetic Testing Services Market,by Service Provider,20202030(US$Million)Table 7.UAE Ge

261、netic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million)Service Provider 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Hospital-Based Laboratories 3.58 3.95 4.35 4.82 5.37 6.02 6.79 7.69 8.76 10.03 11.54 13.0%Diagnostic Laboratories 1.39 1.52

262、1.67 1.84 2.04 2.28 2.55 2.88 3.26 3.72 4.26 12.4%Others 0.78 0.81 0.83 0.86 0.90 0.93 0.97 1.01 1.06 1.10 1.14 4.0%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources 46 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partne

263、rs The Middle East&Africa genetic testing services market for the hospital-based laboratories segment was worth US$4.35 million in 2022 and is projected to reach US$11.54 million by 2030;it is expected to grow at a CAGR of 13.0%from 2022 to 2030.9.1.1.3 South Africa 9.1.1.3.1 Overview South Africa i

264、s undergoing significant developments in healthcare facilities and infrastructure.Developments in healthcare systems are likely to trigger the adoption of advanced technologies for the diagnosis and treatment of various conditions among a large patient population,which creates lucrative opportunitie

265、s for the market.As per the Globocan 2020 data,a total of 108,168 new cancer cases were diagnosed in the country in 2020.Of the total,51,059 cases were observed in males and 57,109 in females.As per the same source,cancer-related mortality accounted for 56,802 in the same year.In South Africa,the in

266、cidences of breast cancer among women are increasing,and it is one of the most common cancers among women in the country.As per the Risk factors for breast cancer among women in Ekurhuleni Metropolitan Municipality,Gauteng province of South Africa,a study published in 2023,breast cancer is common ca

267、ncer among women in South Africa,with an age-standardized incidence rate of 52.6 and an age-standardized mortality rate of 16.0 per 100,000 population.In 2020,breast cancer accounted for 23%of all cancers in women.Additionally,according to the Stellenbosch University data,more than 4.1 million indiv

268、iduals in the country are living with a rare disease.In addition,one in 15 people is estimated to contract a rare disease at some point in their lives in the country.Various universities and organizations work toward raising awareness regarding these diseases in the country.Rare Disease Genomics in

269、South Africa research group,based at Stellenbosch Universitys Faculty of Medicine and Health Sciences and Tygerberg Hospital,hosts a social media campaign every February to enhance awareness about rare diseases.Thus,the increasing number of genetic diseases requiring genetic testing and growing effo

270、rts to raise awareness about the diseases among the countrys population are likely to augment the market.9.1.1.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)South Africa genetic testing services market accounted for US$25.42 Mn in 2022 and it is expected to grow

271、 at a CAGR of 12.4%during the period 2022-2030,to reach US$64.92 Mn in 2030.47 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners Figure 24.South Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)Source:The Insight Partners Analysis,Primary Int

272、erviews,Magazines and Journals,Secondary Sources 9.1.1.3.3 South Africa Genetic Testing Services Market,by Service Type,20202030(US$Million)Table 8.South Africa Genetic Testing Services Market,by Service Type Revenue and Forecast to 2030(US$Million)Service Type 2020 2021 2022 2023 2024 2025 2026 202

273、7 2028 2029 2030 CAGR(20222030)Predictive Testing 9.15 10.10 11.15 12.37 13.81 15.51 17.50 19.87 22.67 26.01 29.99 13.2%Carrier Testing 5.40 5.94 6.53 7.23 8.05 9.01 10.14 11.47 13.05 14.93 17.16 12.8%Prenatal Testing 2.19 2.38 2.59 2.83 3.11 3.44 3.83 4.28 4.81 5.44 6.18 11.5%Newborn Screening 2.61

274、 2.86 3.13 3.46 3.83 4.27 4.79 5.41 6.13 6.99 8.01 12.5%Others 1.81 1.91 2.02 2.14 2.28 2.44 2.62 2.82 3.04 3.30 3.58 7.4%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the predictive tes

275、ting segment was worth US$11.15 million in 2022 and is projected to reach US$29.99 million by 2030;it is expected to grow at a CAGR of 13.2%from 2022 to 2030.21.1623.1825.4228.0331.0934.6738.8843.8449.7056.6664.92202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Y

276、ear 48 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.3.4 South Africa Genetic Testing Services Market,by Disease,20202030(US$Million)Table 9.South Africa Genetic Testing Services Market,by Disease Revenue and Forecast to 2030(US$Million)Disease 2020 2021 20

277、22 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Cancer 9.38 10.42 11.57 12.91 14.50 16.37 18.58 21.20 24.32 28.05 32.51 13.8%Cardiovascular Diseases 4.76 5.24 5.78 6.40 7.13 7.98 8.99 10.19 11.60 13.28 15.29 12.9%Metabolic Diseases 3.66 3.99 4.35 4.78 5.27 5.85 6.53 7.33 8.27 9.38 10.70 11.

278、9%Others 3.35 3.54 3.73 3.94 4.19 4.46 4.77 5.12 5.51 5.94 6.42 7.0%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the cancer segment was worth US$11.57 million in 2022 and is projected t

279、o reach US$32.51 million by 2030;it is expected to grow at a CAGR of 13.8%from 2022 to 2030.9.1.1.3.5 South Africa Genetic Testing Services Market,by Service Provider,20202030(US$Million)Table 10.South Africa Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million

280、)Service Provider 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Hospital-Based Laboratories 13.19 14.55 16.07 17.85 19.93 22.38 25.27 28.69 32.75 37.58 43.35 13.2%Diagnostic Laboratories 5.11 5.63 6.19 6.86 7.63 8.55 9.63 10.90 12.40 14.19 16.33 12.9%Others 2.86 3.01 3.16 3.33

281、 3.52 3.74 3.98 4.25 4.55 4.88 5.24 6.5%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the hospital-based laboratories segment was worth US$16.07 million in 2022 and is projected to reach

282、 US$43.35 million by 2030;it is expected to grow at a CAGR of 13.2%from 2022 to 2030.49 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.4 Rest of Middle East&Africa 9.1.1.4.1 Overview Israel,Iraq,Oman,Iran,Egypt,Turkey,Kuwait,and Kenya are among the major cou

283、ntries in the Rest of Middle East&Africa.The increasing number of cancer cases across the Middle East&Africa is boosting the market growth.According to Globocan 2020,30,000 cancer cases and 11,000 cancer-related death cases are reported yearly in Israel.As per the same source,a total of 131,191 new

284、cancer cases(380.7 per 100,000 people)were reported in 2020 in Iran.Among the total,70,704 new cases were diagnosed in males,while 60,487 were diagnosed in females.The source further stated that 79,136 deaths occurred due to cancer in the same year.In addition,134,632 new cancer cases were diagnosed

285、 in 2020,and 89,042 cancer-related deaths occurred in 2020 in Egypt.Of the total,66,542 cancer cases were diagnosed in men and 68,090 in women.The increasing number of breast cancer cases across the Rest of the Middle East&Africa is boosting the growth of the market.According to Globocan 2020,7,515

286、new breast cancer cases were diagnosed in Iraq,of which 3,019 deaths were reported in the country.The five-year prevalence rate of breast cancer in all ages in the country was 102.46 per 100,000 population.As per the same source,16,967 new breast cancer cases were reported in Iran.The five-year prev

287、alence rate of breast cancer in all ages was 134.46 per 100,000 population in the country.Genetic tests help to detect the probability of the development of a genetic disorder or the same being passed on to the next generation.It helps to detect cancers such as breast,prostate,and colon.The growing

288、healthcare facilities in these countries and the increasing presence of international market players are also estimated to offer a favorable environment for market growth.9.1.1.4.2 Rest of Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)The Rest of Middle East&A

289、frica genetic testing services market accounted for US$22.20 Mn in 2022 and it is expected to grow at a CAGR of 11.2%during the period 2022-2030,to reach US$52.07 Mn in 2030.Figure 25.Rest of Middle East&Africa Genetic Testing Services Market Revenue and Forecast to 2030(US$Mn)Source:The Insight Par

290、tners Analysis,Primary Interviews,Magazines and Journals,Secondary Sources 18.8520.4522.2024.2326.5929.3532.5736.3440.7545.9552.07202020212022202320242025202620272028202920302020-2030Historical YearBase YearForecast Year 50 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Pa

291、rtners 9.1.1.4.3 Rest of Middle East&Africa Genetic Testing Services Market,by Service Type,20202030(US$Million)Table 11.Rest of Middle East&Africa Genetic Testing Services Market,by Service Type Revenue and Forecast to 2030(US$Million)Service Type 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2

292、030 CAGR(20222030)Predictive Testing 8.23 9.05 9.96 11.01 12.25 13.69 15.38 17.38 19.73 22.51 25.82 12.7%Carrier Testing 4.81 5.23 5.69 6.23 6.85 7.58 8.44 9.43 10.61 11.99 13.62 11.5%Prenatal Testing 1.76 1.88 2.01 2.15 2.32 2.52 2.74 3.00 3.30 3.65 4.06 9.2%Newborn Screening 2.32 2.50 2.68 2.90 3.

293、15 3.44 3.78 4.18 4.64 5.17 5.80 10.1%Others 1.72 1.79 1.85 1.93 2.02 2.12 2.23 2.35 2.48 2.62 2.77 5.2%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for the predictive testing segment was w

294、orth US$9.96 million in 2022 and is projected to reach US$25.82 million by 2030;it is expected to grow at a CAGR of 12.7%from 2022 to 2030.9.1.1.4.4 Rest of Middle East&Africa Genetic Testing Services Market,by Disease,20202030(US$Million)Table 12.Rest of Middle East&Africa Genetic Testing Services

295、Market,by Disease Revenue and Forecast to 2030(US$Million)Disease 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Cancer 8.27 9.07 9.95 10.98 12.18 13.58 15.22 17.15 19.43 22.12 25.31 12.4%Cardiovascular Diseases 4.25 4.63 5.05 5.55 6.12 6.79 7.58 8.50 9.58 10.86 12.37 11.8%Meta

296、bolic Diseases 3.22 3.46 3.73 4.03 4.38 4.79 5.26 5.81 6.46 7.21 8.09 10.2%Others 3.11 3.28 3.46 3.67 3.92 4.19 4.51 4.87 5.28 5.76 6.30 7.8%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journals,and Secondary Sources The Middle East&Africa genetic testing services market for

297、 the cancer segment was worth US$9.95 million in 2022 and is projected to reach US$25.31 million by 2030;it is expected to grow at a CAGR of 12.4%from 2022 to 2030.51 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 9.1.1.4.5 Rest of Middle East&Africa Genetic Testi

298、ng Services Market,by Service Provider,20202030(US$Million)Table 13.Rest of Middle East&Africa Genetic Testing Services Market,by Service Provider Revenue and Forecast to 2030(US$Million)Service Provider 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR(20222030)Hospital-Based Laboratories

299、 11.74 12.86 14.09 15.52 17.19 19.15 21.44 24.13 27.30 31.05 35.49 12.2%Diagnostic Laboratories 4.56 4.93 5.33 5.80 6.35 6.98 7.73 8.59 9.61 10.80 12.20 10.9%Others 2.55 2.66 2.77 2.90 3.05 3.22 3.41 3.61 3.85 4.10 4.39 5.9%Source:The Insight Partners Analysis,Primary Interviews,Magazines and Journa

300、ls,and Secondary Sources The Middle East&Africa genetic testing services market for the hospital-based laboratories segment was worth US$14.09 million in 2022 and is projected to reach US$35.49 million by 2030;it is expected to grow at a CAGR of 12.2%from 2022 to 2030.52 Middle East&Africa Genetic T

301、esting Services Market,2020-2030 |The Insight Partners 10.Genetic Testing Services MarketIndustry Landscape 10.1 Overview The developments in the Middle East&Africa genetic testing services market have been characterized by organic and inorganic growth strategies.Various companies are focusing on or

302、ganic growth strategies such as launches,expansion,enhancement,and relocation.Inorganic growth strategies witnessed in the market include mergers&acquisitions,partnerships,and collaborations.These activities have paved the way for the expansion of business and the customer base of market players.Add

303、itionally,growth strategies such as acquisitions and partnerships helped in strengthening their customer base and increase the product portfolio.The companies have maximized their growth with several inorganic strategies to enhance the market value and position in the market.The organic developments

304、 hold 73.33%of the total strategic developments in the market.Whereas the inorganic strategies helped by 26.67%for the growth of the companies.10.2 Growth Strategies in Middle East&Africa Genetic Testing Services Market Figure 26.Growth Strategies in Middle East&Africa Genetic Testing Services Marke

305、t Source:The Insight Partners Analysis 26.67%73.33%Inorganic StrategiesOrganic Strategies 53 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 10.3 Organic Growth Strategies 10.3.1 Overview Various companies have adopted organic growth strategies in genetic testing s

306、ervices market.Some of the activities that have helped the companies promote their growth are launches,expansion,relocation activities.23andMe Holding Co is among the companies that have been implementing organic strategies,which,in turn,have brought about various changes in the global health econom

307、ics and outcomes research services market.The companies have utilized strategies such as new product launch to expand their geographic reach and capacity to cater to a large number of customers.Some of the organic developments are listed below.Table 14.Recent Organic Growth Strategies in Middle East

308、&Africa Genetic Testing Services Market CompanyCompany Month&YearMonth&Year CategoryCategory DescriptionDescription 23andMe Holding Co Nov-2023 Product Launch 23andMe Holding Co launched 23andMe+Total Health,a new membership that offers that provides clinical grade exome sequencing,biannual blood te

309、sting,and access to genetics-based clinical care.Illumina Inc.Nov-2023 Company News Illumina Inc.announced the launch of the Global Health Access Initiative.It is anticipated that the effort will help low-and middle-income nations have access to pathogen sequencing tools for public health.The progra

310、m will address major international logistics and supply chain challenges and offer discounted pricing structures for Illuminas eligible sequencing products to qualified global health funding entities.It was developed with input from customers,funders,and market facilitators,including the nonprofit F

311、IND.23andMe Holding Co Oct-2023 Product Launch 23andMe Holding Co launched Health Action Plan,a new digital tool that utilizes results from genetic reports,health history survey data,and blood and biomarker data to provide a tailored set of health recommendations to its members.CENTOGENE Oct-2023 Pr

312、oduct Launch The company expanded its Multiomic Diagnostic Portfolio with incorporation of transcriptomic analysis.It allows to combine DNA sequencing,biochemical testing,and RNA sequencing to improve testing capability.NeoGenomics Inc Oct-2023 Product Launch NeoGenomics Inc launched two new tests t

313、o expand its portfolio of cancer products including Early-stage Non-Small Cell Lung Cancer Panel and the Neo Comprehensive-Heme Cancers Panel.Quest Diagnostics Inc Jul-2023 Product Launch Quest Diagnostics Inc announced launch of first consumer-initiated genetic test,Genetic Insights.The test can be

314、 accessed at via its consumer health business.With the launch of advanced technology and end-to-end support,including personalized health reports and genetic counseling,consumers will be able to understand their potential risk of having certain inheritable health issues.Laboratory Corp of America Ho

315、ldings Jun-2023 Company News Laboratory Corp of America Holdings announced it has completed the spin-off of Fortrea.Fortrea was the companys newly formed independent Contract Research Organization that provides Phase I-IV clinical trial management,patient access,and technology solutions to pharmaceu

316、tical and biotechnology organizations globally.After the spin-off,Fortrea will be enlisted as a new entity and will begin trading on the NASDAQ Stock Market under the symbol FTRE effective from July 3,2023.54 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners CompanyC

317、ompany Month&YearMonth&Year CategoryCategory DescriptionDescription CENTOGENE Apr-2023 Product Launch The company released FilterTool,a web-based application for interpreting genetic data.FilterTool connects with CentoCloud to effectively show,filter,select,and categorize pertinent genetic variation

318、s found through Next Generation Sequencing(NGS)data processing.Ambry Genetics Corp Nov-2022 Product News Ambry Genetics Corp launched a reproductive health program.It driven by its Comprehensive Assessment Risk and Education program,which is a digital platform that enhances the patient and provider

319、experience through easier access to genetic education,testing,reporting and counseling.Eurofins Scientific Sep-2022 Product Launch The niPGT-A screening test aims to enable in vitro fertilization centers to produce quality embryo samples,avoiding the need for embryo biopsies.It will allow medical pr

320、actitioners to determine chromosomal abnormalities in in vitro fertilization embryos,which may lead to complications during pregnancy.Eurofins Scientific Feb-2022 Expansion Eurofins Scientifics subsidiary,Eurofins Clinical Testing Lux Sarl,acquired Genetic Testing Service JSC,located in Vietnam.Thro

321、ugh this acquisition,the company aims to expand its network in Asia and strengthen its global network of clinical diagnostic laboratories,which primarily focus on specialized and advanced genetic testing.Source:The Insight Partners Analysis 10.4 Inorganic Growth Strategies 10.4.1 Overview The inorga

322、nic growth strategies undertaken by the companies operating in the global market of genetic testing services include collaboration,partnership,agreement&joint venture.During 20202022,companies such as Ambry Genetics Corp has undertaken various inorganic strategies that have bought about remarkable d

323、evelopments in the Middle East&Africa genetic testing services market due to the involvement of major players which has led to availability of better products in the market.Table 15.Recent Inorganic Growth Strategies in the Middle East&Africa Genetic Testing Services Market CompanyCompany Month&Year

324、Month&Year CategoryCategory DescriptionDescription 23andMe Holding Co Oct-2023 Collaboration 23andMe Holding Co announced a non-exclusive data license collaboration with GSK plc,which enables GSK to conduct drug target discovery and other research using the 23andMe database.Ambry Genetics Corp Apr-2

325、023 Collaboration Ambry Genetics Corp collaborated with LifeStrands Genomics to offer clinical genetic testing services in Singapore.Both the companies will support the Clinical Implementation Pilots(CIPs)for Phase II of Singapores National Precision Medicine(NPM)programme.Ambry Genetics Corp Jan-20

326、23 Partnership Ambry Genetics Corp partnered with Unilabs to enhance genetic testing services for biopharma businesses in Europe,Latin America,and the Middle East,where it does not have a physical presence.It will cater to these markets by utilizing Unilabs genomic lab services and variant interpret

327、ation skills.Ambry,on the other hand,will provide Unilabs with its variant assessment skills.55 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners CompanyCompany Month&YearMonth&Year CategoryCategory DescriptionDescription Exact Sciences Jan-2022 Mergers and Acquisiti

328、ons Exact Sciences has acquired PreventionGenetics,a genetic testing laboratory,to accelerate the availability of hereditary cancer testing for more patients.Source:The Insight Partners Analysis 56 Middle East&Africa Genetic Testing Services Market,2020-2030 |The Insight Partners 11.Company Profiles

329、 11.1 Eurofins Scientific SE 11.1.1 Key Facts Eurofins Scientific SEEurofins Scientific SE Founded 1987 Corporate Address 23 Val Fleuri,L-1526,Luxembourg Headquarter Luxembourg Telephone+32 2 7661620 URL Location Global Exchange Ticker Symbol XLUX:ERF Number of Employees 61,379 Fiscal Year End Dec-2

330、022 11.1.2 Business Description Eurofins Scientific SE is a life sciences company that provides analytical testing services to clients in various industries.It provides forensic services,food and feed testing,environmental testing,biopharma services,pharma discovery services,pharma early development

331、,a pharma central laboratory,biopharma product testing,and product testing.The companys analytical techniques aid in assessing the purity,authenticity,and safety of biological goods and chemicals.To provide a variety of services,it makes use of its expertise in information technology and logistics.The company has operations in South America,the Middle East,Asia Pacific,Europe,and North America.As of December 2022,the company served 61 countries with 900 laboratories,a portfolio of over 200,000 analytical methods,and mo